Palestine News

Ocrelizumab cuts disability progression in primary progressive MS trial

Written by

wpadmin

in

Credit: Unsplash/CC0 Public Domain

A major international Phase III clinical trial, led by Queen Mary University of London, has found that…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts